Bausch + Lomb Corp risk profile
66 Stretched several inputs deteriorating together
Measured 2 September 2026 from BLCO's filed statements. Recomputed nightly.
66 (Stretched), driven by Leverage and coverage at 84, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 28 | Normal | Stable | One-year price volatility — 29.6% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 81 | Acute | Stable | Capital spending against operating cash — 1.23x |
| Leverage and coverage | 84 | Acute | Worsening | Net debt to EBITDA — 8.74x |
| Competitive position | 64 | Stretched | Stable | Operating-margin gap against peers — -5.8 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 22Johnson & Johnson 37Abbvie Inc 48Roche Holding AG 32Merck & Co Inc 26Novartis AG 25Astrazeneca plc 30AMGEN Inc 33Thermo Fisher Scientific Inc 45Novo Nordisk A/S 23Abbott Laboratories 43Gilead Sciences Inc 31
Financials, valuation and price history for Bausch + Lomb Corp